Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Br J Haematol ; 103(2): 543-51, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9827933

RESUMO

HLA-mismatched bone marrow transplantation (BMT) is hampered by three major complications: graft rejection, acute graft-versus-host disease (aGVHD) and delayed immune reconstitution. Infusion of anti-LFA1 plus anti-CD2 monoclonal antibodies (MAb), combined with ex-vivo T-cell depletion of the graft, was efficient in preventing graft rejection and aGVHD. Nevertheless, disease-free survival was limited by the high frequency of lethal infections, including EBV-induced lymphoproliferative disease (BLPD), which originates mostly from donor B cells, with an incidence of 5-30%. To decrease the rate of this complication, ex-vivo B-cell depletion was attempted. This study compares a group of 19 patients who received a T- and B-cell-depleted marrow from an HLA-mismatched related donor with a retrospective control group of 19 patients, who had received T-cell-depleted marrow by the same method. The level of T-cell depletion was similar in the two groups. For B-cell depletion, two different methods were compared. The median number of B cells infused in the study group was 0.46/kg. Engraftment and aGVHD incidence were similar in the two groups. No EBV donor-derived BPLD occurred in the study group, compared with seven in the control group, four of whom died because of EBV-BPLD. Event-free survival was significantly different between the two groups. We conclude that ex-vivo B-cell depletion of the graft may be a useful means of preventing EBV-BPLD, and warrants further study on a larger group of patients.


Assuntos
Linfócitos B/imunologia , Transplante de Medula Óssea/métodos , Infecções por Vírus Epstein-Barr/prevenção & controle , Transtornos Linfoproliferativos/prevenção & controle , Condicionamento Pré-Transplante/métodos , Transplante de Medula Óssea/efeitos adversos , Separação Celular , Criança , Pré-Escolar , Sobrevivência de Enxerto/imunologia , Doença Enxerto-Hospedeiro/prevenção & controle , Teste de Histocompatibilidade , Humanos , Lactente , Estudos Retrospectivos , Taxa de Sobrevida , Linfócitos T/imunologia
2.
Agents Actions Suppl ; 39: 267-72, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8456640

RESUMO

Human articular cartilage cells were transfected with the t.-sensitive polyomavirus large T antigen of SV40. Several immortalized chondrocyte cell lines were obtained. The types of acidic polysaccharides and of collagen synthesized suggest dedifferentiation in the in vitro culture system used afterwards to obtain large numbers of cells.


Assuntos
Cartilagem Articular/citologia , Linhagem Celular , Antígenos Transformantes de Poliomavirus/imunologia , Cartilagem Articular/imunologia , Diferenciação Celular , Cromatografia por Troca Iônica , Colágeno/metabolismo , Cabeça do Fêmur/citologia , Humanos , Ácido Hialurônico/química , Ácido Hialurônico/metabolismo , Fenótipo , Proteoglicanas/química , Proteoglicanas/metabolismo , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA